» Articles » PMID: 29472921

Kinetics of HIV-Specific CTL Responses Plays a Minimal Role in Determining HIV Escape Dynamics

Overview
Journal Front Immunol
Date 2018 Feb 24
PMID 29472921
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Cytotoxic T lymphocytes (CTLs) have been suggested to play an important role in controlling human immunodeficiency virus (HIV-1 or simply HIV) infection. HIV, due to its high mutation rate, can evade recognition of T cell responses by generating escape variants that cannot be recognized by HIV-specific CTLs. Although HIV escape from CTL responses has been well documented, factors contributing to the timing and the rate of viral escape from T cells have not been fully elucidated. Fitness costs associated with escape and magnitude of the epitope-specific T cell response are generally considered to be the key in determining timing of HIV escape. Several previous analyses generally ignored the kinetics of T cell responses in predicting viral escape by either considering constant or maximal T cell response; several studies also considered escape from different T cell responses to be independent. Here, we focus our analysis on data from two patients from a recent study with relatively frequent measurements of both virus sequences and HIV-specific T cell response to determine impact of CTL kinetics on viral escape. In contrast with our expectation, we found that including temporal dynamics of epitope-specific T cell response did not improve the quality of fit of different models to escape data. We also found that for well-sampled escape data, the estimates of the model parameters including T cell killing efficacy did not strongly depend on the underlying model for escapes: models assuming independent, sequential, or concurrent escapes from multiple CTL responses gave similar estimates for CTL killing efficacy. Interestingly, the model assuming sequential escapes (i.e., escapes occurring along a defined pathway) was unable to accurately describe data on escapes occurring rapidly within a short-time window, suggesting that some of model assumptions must be violated for such escapes. Our results thus suggest that the current sparse measurements of temporal CTL dynamics in blood bear little quantitative information to improve predictions of HIV escape kinetics. More frequent measurements using more sensitive techniques and sampling in secondary lymphoid tissues may allow to better understand whether and how CTL kinetics impacts viral escape.

Citing Articles

No Difference in the Prevalence of HIV-1 Cytotoxic T-Lymphocyte-Associated Escape Mutations in Viral Sequences from Early and Late Parts of the HIV-1 Subtype C Pandemic in Botswana.

Mokaleng B, Choga W, Bareng O, Maruapula D, Ditshwanelo D, Kelentse N Vaccines (Basel). 2023; 11(5).

PMID: 37243104 PMC: 10221913. DOI: 10.3390/vaccines11051000.


A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies.

McCann C, van Dorp C, Danesh A, Ward A, Dilling T, Mota T J Exp Med. 2021; 218(7).

PMID: 33988715 PMC: 8129803. DOI: 10.1084/jem.20201908.


A de novo approach to inferring within-host fitness effects during untreated HIV-1 infection.

Illingworth C, Raghwani J, Serwadda D, Sewankambo N, Robb M, Eller M PLoS Pathog. 2020; 16(6):e1008171.

PMID: 32492061 PMC: 7295245. DOI: 10.1371/journal.ppat.1008171.


Modeling the immune response to HIV infection.

Conway J, Ribeiro R Curr Opin Syst Biol. 2019; 12:61-69.

PMID: 31463420 PMC: 6713454. DOI: 10.1016/j.coisb.2018.10.006.


Time Intervals in Sequence Sampling, Not Data Modifications, Have a Major Impact on Estimates of HIV Escape Rates.

Ganusov V Viruses. 2018; 10(3).

PMID: 29495443 PMC: 5869492. DOI: 10.3390/v10030099.

References
1.
Ganusov V, De Boer R . Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection. PLoS Comput Biol. 2006; 2(3):e24. PMC: 1420660. DOI: 10.1371/journal.pcbi.0020024. View

2.
Althaus C, De Boer R . Dynamics of immune escape during HIV/SIV infection. PLoS Comput Biol. 2008; 4(7):e1000103. PMC: 2423483. DOI: 10.1371/journal.pcbi.1000103. View

3.
Mansky L, Temin H . Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol. 1995; 69(8):5087-94. PMC: 189326. DOI: 10.1128/JVI.69.8.5087-5094.1995. View

4.
Borrow P, Lewicki H, Hahn B, Shaw G, Oldstone M . Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994; 68(9):6103-10. PMC: 237022. DOI: 10.1128/JVI.68.9.6103-6110.1994. View

5.
Garcia V, Feldman M, Regoes R . Investigating the Consequences of Interference between Multiple CD8+ T Cell Escape Mutations in Early HIV Infection. PLoS Comput Biol. 2016; 12(2):e1004721. PMC: 4735108. DOI: 10.1371/journal.pcbi.1004721. View